Comparison of the long-term prognostic value of different frailty instruments in older inpatients: a 5-year prospective cohort study

比较不同衰弱评估工具对老年住院患者长期预后价值的评估:一项为期5年的前瞻性队列研究

阅读:2

Abstract

BACKGROUND: Frailty is associated with increased mortality in older adults, but limited studies compare frailty instruments among inpatients with long-term follow-up. AIMS: To evaluate five frailty scales for predicting 5-year all-cause mortality in older inpatients. METHODS: This prospective cohort study enrolled 917 inpatients aged ≥ 65 years. We used five commonly used scales [Clinical Frailty Scale (CFS), FRAIL, Fried, Edmonton, and the comprehensive geriatric assessment-frailty index (CGA-FI)] to screen or assess frailty and then conducted a 5-year telephone follow-up. The primary endpoint was 5-year all-cause mortality. The predictive value of different frailty scales was compared using Kaplan-Meier (K-M) survival analysis, COX regression models, and the receiver operating characteristic (ROC) curves. RESULTS: The prevalence of frailty ranged from 19.5 to 36.5%. Both K-M survival curves and Cox regression confirmed that frailty patients had higher mortality risk across all scales. After multivariate adjustment, the hazard ratios from highest to lowest, were: CGA-FI, FRAIL, Fried, CFS, and Edmonton (all p < 0.05). Frailty demonstrated moderate performance, with area under the curves (AUCs) ranging from 0.70 to 0.75 (all p < 0.001). CGA-FI had the largest AUC of 0.724, revealing the best predictive value, while FRAIL had the smallest AUC of 0.666. The AUCs of Fried, Edmonton, and CFS gradually decreased, with no statistical differences. Furthermore, CFS has the highest sensitivity (77.5%). CONCLUSIONS: Frailty identified by all scales is associated with an increased risk of long-term mortality. CFS is the preferred frailty screening scale, while CGA-FI is the most accurate assessment scale. Trial registration ChiCTR1800017204 (07/18/2018).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。